{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:13:45Z","timestamp":1782303225703,"version":"3.54.5"},"reference-count":78,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ejim.2013.03.003","type":"journal-article","created":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T14:17:12Z","timestamp":1365430632000},"page":"583-589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Update on polymyalgia rheumatica"],"prefix":"10.1016","volume":"24","author":[{"given":"Nicol\u00f2","family":"Pipitone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Salvarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2013.03.003_bb0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.humimm.2008.10.011","article-title":"Interleukin-1RN gene polymorphisms in elderly patients with rheumatic inflammatory chronic conditions: association of IL-1RN*2\/2 genotype with polymyalgia rheumatica","volume":"70","author":"Alvarez-Rodriguez","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0010","first-page":"502","article-title":"Intercellular adhesion molecule-1 gene polymorphisms in isolated polymyalgia rheumatica","volume":"29","author":"Amoli","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/ard.16.2.230","article-title":"Myalgic syndrome with constitutional effects: polymyalgia rheumatica","volume":"16","author":"Barber","year":"1957","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.03.003_bb0020","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.38.5.434","article-title":"An evaluation of criteria for polymyalgia rheumatica","volume":"38","author":"Bird","year":"1979","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.03.003_bb0025","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/rheumatology\/kel376","article-title":"Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients","volume":"46","author":"Blockmans","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2013.03.003_bb0030","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/art.1780300308","article-title":"Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982\u20131985","volume":"30","author":"Boesen","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.03.003_bb0035","first-page":"703","article-title":"Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse\/recurrence in polymyalgia rheumatica","volume":"33","author":"Boiardi","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0040","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/bmj.2.1450.811","article-title":"Senile rheumatic gout","volume":"2","author":"Bruce","year":"1888","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2013.03.003_bb0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/rheumatology\/keq450","article-title":"Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis and prognosis","volume":"51","author":"Camellino","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2013.03.003_bb0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/ard.58.4.230","article-title":"Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study","volume":"58","author":"Cantini","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.03.003_bb0055","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/1529-0131(200105)44:5<1155::AID-ANR198>3.0.CO;2-N","article-title":"Inflamed shoulder structures in polymyalgia rheumatica with normal erythrocyte sedimentation rate","volume":"44","author":"Cantini","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.03.003_bb0060","first-page":"1049","article-title":"Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case\u2013control study","volume":"28","author":"Cantini","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0065","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-141-7-200410050-00005","article-title":"Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial","volume":"141","author":"Caporali","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.03.003_bb0070","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/art.23095","article-title":"Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study","volume":"57","author":"Catanoso","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.03.003_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.04.2011.4135","article-title":"Successful use of tocilizumab in polymyalgic onset biopsy positive GCA with large vessel involvement","volume":"2011","author":"Christidis","year":"2011","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ejim.2013.03.003_bb0080","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: a 10-year epidemiologic and clinical study","volume":"97","author":"Chuang","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.03.003_bb0085","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","article-title":"BSR and BHPR guidelines for the management of polymyalgia rheumatica","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2013.03.003_bb0090","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"71","author":"Dasgupta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.03.003_bb0095","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/rheumatology\/29.6.456","article-title":"Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis","volume":"29","author":"Dasgupta","year":"1990","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0100","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/art.1780280905","article-title":"The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration","volume":"28","author":"Deal","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.03.003_bb0105","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/ard.2010.133850","article-title":"Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus","volume":"70","author":"Dejaco","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.03.003_bb0110","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0161-6420(80)35110-5","article-title":"C-reactive protein in giant cell (cranial, temporal) arteritis","volume":"87","author":"Eshaghian","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejim.2013.03.003_bb0115","first-page":"123","article-title":"Evidence for synovitis in active polymyalgia rheumatica: sonographic study in a large series of patients","volume":"29","author":"Frediani","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0120","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1586\/eci.10.59","article-title":"Current understanding and management of giant cell arteritis and polymyalgia rheumatica","volume":"6","author":"Ghosh","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0125","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/ar293","article-title":"Genetic epidemiology. Giant cell arteritis and polymyalgia rheumatica","volume":"3","author":"Gonzalez-Gay","year":"2001","journal-title":"Arthritis Res"},{"key":"10.1016\/j.ejim.2013.03.003_bb0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/sarh.2002.50025","article-title":"Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica","volume":"33","author":"Gonzalez-Gay","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.03.003_bb0135","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.20231","article-title":"Giant cell arteritis without clinically evident vascular involvement in a defined population","volume":"51","author":"Gonzalez-Gay","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.03.003_bb0140","first-page":"2729","article-title":"Polymyalgia rheumatica and biopsy-proven giant cell arteritis exhibit different HLA-DRB1* associations","volume":"30","author":"Gonzalez-Gay","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0145","first-page":"2179","article-title":"The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain","volume":"27","author":"Gonzalez-Gay","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0150","first-page":"179","article-title":"IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis","volume":"20","author":"Gonzalez-Gay","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0155","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.03.003_bb0160","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3899\/jrheum.091185","article-title":"Tocilizumab ameliorates clinical symptoms in polymyalgia rheumatica","volume":"37","author":"Hagihara","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0165","first-page":"S29","article-title":"Laboratory investigations useful in the evaluation of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA)","volume":"18","author":"Hazleman","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0170","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0049-0172(84)90012-X","article-title":"Long-term follow-up of polymyalgia rheumatica: evidence for synovitis","volume":"13","author":"Healey","year":"1984","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.03.003_bb0175","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/archinternmed.2009.352","article-title":"Treatment of polymyalgia rheumatica: a systematic review","volume":"169","author":"Hernandez-Rodriguez","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2013.03.003_bb0180","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/ard.2009.113555","article-title":"Ultrasonographic monitoring of response to therapy in polymyalgia rheumatica","volume":"69","author":"Jimenez-Palop","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.03.003_bb0185","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/art.21067","article-title":"Remitting seronegative symmetrical synovitis with pitting edema of the hands: ultrasound, color doppler ultrasound, and magnetic resonance imaging findings","volume":"53","author":"Klauser","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.03.003_bb0190","doi-asserted-by":"crossref","first-page":"R176","DOI":"10.1186\/ar3140","article-title":"Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial","volume":"12","author":"Kreiner","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ejim.2013.03.003_bb0195","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/ard.48.8.667","article-title":"Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica\/giant cell arteritis on presentation and during follow up","volume":"48","author":"Kyle","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.03.003_bb0200","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/ard.52.12.847","article-title":"The clinical and laboratory course of polymyalgia rheumatica\/giant cell arteritis after the first two months of treatment","volume":"52","author":"Kyle","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.03.003_bb0205","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/ard.2003.011379","article-title":"A disease activity score for polymyalgia rheumatica","volume":"63","author":"Leeb","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.03.003_bb0210","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1136\/ard.2002.002618","article-title":"EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT)","volume":"62","author":"Leeb","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.03.003_bb0215","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/rheumatology\/keh143","article-title":"Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica","volume":"43","author":"Lopez-Hoyos","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2013.03.003_bb0220","first-page":"1340","article-title":"Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis","volume":"17","author":"Lundberg","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0225","first-page":"391","article-title":"RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis","volume":"18","author":"Makki","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0230","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/1529-0131(200008)43:8<1749::AID-ANR11>3.0.CO;2-K","article-title":"Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms","volume":"43","author":"Mattey","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.03.003_bb0235","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3899\/jrheum.110851","article-title":"Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study","volume":"39","author":"Mazzantini","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0240","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/rheumatology\/kes294","article-title":"Plasma fibrinogen is an accurate marker of disease activity in patients with polymyalgia rheumatica","volume":"52","author":"McCarthy","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2013.03.003_bb0245","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1001\/jama.1985.03360190069027","article-title":"Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome","volume":"254","author":"McCarty","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2013.03.003_bb0250","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/art.1780390719","article-title":"Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment","volume":"39","author":"Meliconi","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.03.003_bb0255","first-page":"519","article-title":"Joint imaging in polymyalgia rheumatica","volume":"51","author":"O'Duffy","year":"1976","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ejim.2013.03.003_bb0260","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1053\/sarh.2003.49993","article-title":"Hypothalamic\u2013pituitary\u2013adrenocortical axis function in patients with polymyalgia rheumatica and giant cell arteritis","volume":"32","author":"Pacheco","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.03.003_bb0265","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/art.21585","article-title":"Calcium pyrophosphate deposition disease mimicking polymyalgia rheumatica: a prospective followup study of predictive factors for this condition in patients presenting with polymyalgia symptoms","volume":"53","author":"Pego-Reigosa","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.03.003_bb0270","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/ard.2005.038901","article-title":"Seasonal pattern in the onset of polymyalgia rheumatica","volume":"64","author":"Perfetto","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.03.003_bb0275","series-title":"EULAR compendium on rheumatic diseases","first-page":"556","article-title":"Polymyalgia rheumatica and giant cell arteritis","author":"Pipitone","year":"2009"},{"key":"10.1016\/j.ejim.2013.03.003_bb0280","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.berh.2008.09.009","article-title":"The role of infectious agents in the pathogenesis of vasculitis","volume":"22","author":"Pipitone","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0285","first-page":"711","article-title":"Polymyalgia rheumatica in a married couple","volume":"5","author":"Rust","year":"2012","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ejim.2013.03.003_bb0290","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s10067-012-2016-2","article-title":"Ultrasound assessment of new onset bilateral painful shoulder in patients with polymyalgia rheumatica and rheumatoid arthritis","volume":"31","author":"Ruta","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0295","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/ard.2007.084723","article-title":"Cervical interspinous bursitis in active polymyalgia rheumatica","volume":"67","author":"Salvarani","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.03.003_bb0300","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"347","author":"Salvarani","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.03.003_bb0305","first-page":"S23","article-title":"Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis","volume":"21","author":"Salvarani","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0310","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"372","author":"Salvarani","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2013.03.003_bb0315","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/1529-0131(199807)41:7<1221::AID-ART12>3.0.CO;2-W","article-title":"Distal musculoskeletal manifestations in polymyalgia rheumatica: a prospective followup study","volume":"41","author":"Salvarani","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.03.003_bb0320","first-page":"760","article-title":"Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study","volume":"30","author":"Salvarani","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0325","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-127-1-199707010-00005","article-title":"Proximal bursitis in active polymyalgia rheumatica","volume":"127","author":"Salvarani","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.03.003_bb0330","first-page":"1215","article-title":"Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica\/giant cell arteritis: association with disease risk and severity","volume":"27","author":"Salvarani","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0335","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780380311","article-title":"Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970\u20131991","volume":"38","author":"Salvarani","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.03.003_bb0340","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-123-3-199508010-00006","article-title":"The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern","volume":"123","author":"Salvarani","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.03.003_bb0345","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-146-9-200705010-00005","article-title":"Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial","volume":"146","author":"Salvarani","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.03.003_bb0350","first-page":"205","article-title":"Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy","volume":"5","author":"Salvarani","year":"1987","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0355","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/ken437","article-title":"Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the GRACG prospective study","volume":"48","author":"Schmidt","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejim.2013.03.003_bb0360","first-page":"w13156","article-title":"Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series","volume":"141","author":"Seitz","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.ejim.2013.03.003_bb0365","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.rdc.2007.09.002","article-title":"Vasculitis: a collection of pearls and myths","volume":"33","author":"Stone","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.ejim.2013.03.003_bb0370","first-page":"299","article-title":"Antibodies against Chlamydia pneumoniae, cytomegalovirus, enteroviruses and respiratory syncytial virus in patients with polymyalgia rheumatica","volume":"15","author":"Uddhammar","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2013.03.003_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/acr.21750","article-title":"Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, takayasu arteritis) and polymyalgia rheumatica","author":"Unizony","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ejim.2013.03.003_bb0380","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.55.4.218","article-title":"Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?","volume":"55","author":"van der Veen","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2013.03.003_bb0385","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/1529-0131(199905)42:5<844::AID-ANR2>3.0.CO;2-M","article-title":"Arterial wall injury in giant cell arteritis","volume":"42","author":"Weyand","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2013.03.003_bb0390","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-121-7-199410010-00003","article-title":"Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis","volume":"121","author":"Weyand","year":"1994","journal-title":"Ann Intern Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513000873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513000873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T23:20:38Z","timestamp":1539732038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620513000873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":78,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0953620513000873"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2013.03.003","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on polymyalgia rheumatica","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2013.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}